Table 9.
Rapamycin and gene expression studies using microarrays in mice
Strain, sex | Intervention | Organ | Genes up-regulated | Genes down-regulated | Pathways involved | Reference |
---|---|---|---|---|---|---|
Male and female C57BL/6J | Oral rapamycin (encapsulated, 14 ppm) initiated at 4 months of age for 21 months | Liver | 159 (males), 2,504 (females) | 129 (males), 2,257 (females) | 13 | [77] |
Oral rapamycin (encapsulated, 14 ppm) initiated at 19 months of age for 6 months | 32 (males), 675 (females) | 68 (males), 752 (females) | 3 | |||
Male C57BL/6 | Oral rapamycin (encapsulated, 14 ppm) initiated at 2 months of age with duration of 6 months | Liver | 783 | 628 | 105 | [78] |
40 % dietary restriction initiated at 2 months of age with duration of 6 months | 1,621 | 256 | 88 | |||
40 % dietary restriction combined with oral rapamycin treatment (encapsulated, 14 ppm) initiated at 2 months of age with duration of 6 months | 2,558 | 1,130 | 170 |